Clinical Trial Update: The Efficacy of Metformin Produced by Pars Mino Co in Comparison With Canadian Apotex Co. [Phase 4]

View source ↗

Summary

Phase 4 trial comparing metformin produced by Pars Mino Co with Canadian Apotex Co in type 2 diabetes patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Metformin (Apotex product) (Metformin)
• Metformin (Pars Mino Co product) (Metformin)

Snippet

Sponsor: Zanjan University of Medical Sciences | Conditions: Diabetes Mellitus, Type 2 AND Metformin | Phase 4 | Status: COMPLETED